<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Plasmodium falciparum ensures amino acid supply <br /> with multiple acquisition pathways redundant <br /> proteolytic enzyme systems <br /> Jun Liu*, Eva S. Istvan*, Ilya Y. Gluzman, Julia Gross, Daniel E. Goldberg&#226;&#8364;&#160; <br /> Howard Hughes Medical Institute, Departments Medicine Molecular Microbiology, Washington University School Medicine, 660 South Euclid <br /> Avenue, Box 8230, St. Louis, MO 63110 <br />  <br /> Edited Louis H. Miller, National Institutes Health, Rockville, MD, approved April 24, 2006 (received review March 8, 2006) <br />  <br /> Degradation host hemoglobin human malaria parasite                     strict (13&#226;&#8364;&#8220;15). Knockouts plasmepsins individually in <br /> Plasmodium falciparum massive metabolic process. What role                  combination (plasmepsin IV&#229;&#8230;&#190;I double <span id='am-162' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-163' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-166' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-167' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-174' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-176' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-177' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-178' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-182' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-186' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-188' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-191' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-192' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-193' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-195' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-197' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-203' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-204' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-205' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-207' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-214' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-215' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-216' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-217' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-221' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-233' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-238' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-239' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span>knockout</span>) parasites <br /> this degradation plays essential parasite                  slightly impaired growth (5, 16), falcipain-2 <br /> <span id='am-6' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-7' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-11' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-15' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-23' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-27' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-30' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-34' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-40' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-42' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-44' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-48' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-51' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-66' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-78' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-81' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-83' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span>survival</span> established, roles                    knockout shows normal growth (17). The effect aspartic <br /> various degradative enzymes clearly defined. We report                 protease inhibitors potentiated combined cysteine <br /> P. falciparum grow medium containing single amino acid                  protease inhibitors used falcipain-2 knockout parasites (15, <br /> (isoleucine, amino acid missing human hemoglobin).                 17). Therefore evidence suggests overlap and <br /> In medium, growth hemoglobin-degrading enzyme gene                       food vacuole proteolytic families; relative roles <br /> knockout lines (missing falcipain-2 plasmepsins in <br />                                                                                  remain unclear. <br /> combination) impaired. Blockade plasmepsins potent <br />                                                                                     We cultured P. falciparum parasites able <br /> inhibitor pepstatin A minimal effect WT parasite growth <br />                                                                                  grow medium containing isoleucine (the amino <br /> but kills falcipain-2 knockout parasites low concentrations and <br />                                                                                  acid lacking human hemoglobin) sole exog- <br /> is potent falcipain-2, plasmepsin I IV triple <br /> knockout parasites. We conclude that: (i ) hemoglobin degradation <br />                                                                                  enously supplied amino acid. We used medium <span id='am-5' about='protege:TO' typeof='owl:Thing'>to</span> <br /> is necessary parasite survival; (ii ) hemoglobin degradation              explore function hemoglobin degradation the <br /> sufficient supply parasite&#226;&#8364;&#8482;s amino acid requirements;             roles food vacuole plasmepsins falcipains. <br /> (iii ) external amino acid acquisition hemoglobin digestion are <br />                                                                                  Results <br /> partially redundant <span id='am-1' about='Thesaurus:Nutrient' typeof='owl:Thing'>nutrient</span> pathways; (iv) hemoglobin degrada- <br /> tion uses dual protease families overlapping function;                  Amino Acid Requirements Parasite Growth. Divo et al. (4) <br /> (v) hemoglobin-degrading plasmepsins promising drug                      discovered P. falciparum grow short term culture <br /> targets.                                                                         medium containing amino acids (cysteine, glutamate, <br />                                                                                  glutamine, methionine, isoleucine) (5AA). After 6 days in <br /> hemoglobin &#229;&#8230;&#169; malaria &#229;&#8230;&#169; protease                                                  medium, parasitemia 5% rich RPMI medium <br />                                                                                  1640 containing 20 amino acids (5). This finding suggested <br />                                                                                  P. falciparum relies exogenous amino acid supplemen- <br /> D     uring intraerythrocytic stage, Plasmodium falciparum in- <br />       gests degrades 75% host cell hemoglobin (1). <br /> This massive catabolic process takes place inside acidic <br />                                                                                  tation growth requirement. The minimal growth <br />                                                                                  achieved 5AA likely depend hemoglobin <br /> food vacuole involves pathway proteolytic enzymes (2).                  degradation, amino acid biosynthetic pathways are <br /> Despite extensive study, purpose hemoglobin degradation                   missing parasite (3, 18) added amino acids <br /> and relative role different proteases remain unclear. Several             lacking limited hemoglobin. To examine role each <br /> functions proposed hemoglobin catabolism. Provi-                   amino acids, assessed parasite growth 5AA <br /> sion nutrients parasite energy and&#229;&#8230;&#190;or protein synthesis needs             lacking amino acids separately. Trophozoite- <br /> is obvious potential role. Some radioactivity labeled                    stage parasites incubated 25 h assessed devel- <br /> hemoglobin incorporated parasite protein (3). However, P.                opmental progression flow cytometry. Parasites incubated <br /> falciparum grows poorly medium lacking seven amino                 5AA progressed schizont stage many <br /> acids sluggish grown medium containing              reinvaded fresh RBCs, evidenced rise parasitemia and <br /> amino acids reliant (4, 5). These findings suggest           emergence peak corresponding ring-stage parasites (Fig. <br /> a dependence exogenously supplied amino acids. Also,                     1A). Parasites incubated culture medium amino <br /> strains P. falciparum digest considerably hemoglobin,                acids (no AA) stalled development. When one <br /> parasites excrete substantial portion amino acids               amino acid time omitted 5AA, parasites developed <br /> liberated hemoglobin (6). Alternatively, suggested <br />                                                                                  actually grew slightly better 5AA. In <br /> that parasite digests hemoglobin make room itself the <br /> erythrocyte (6) maintain osmotic balance (7). The assump- <br /> tions inherent osmotic hypothesis controversial (8),              Conflict statement: No conflicts declared. <br /> the association volume hemoglobin correlative. Thus,             This paper submitted directly (Track II) PNAS office. <br /> it remains unclear parasite degrades hemoglobin.                         Freely available online PNAS open access option. <br />    With regard enzymology hemoglobin degradation, <br />                                                                                  Abbreviations: AA, culture medium amino acids; I medium, AA supple- <br /> two families proteases play prominent roles. Four aspartic                    mented isoleucine sole amino acid; 5AA, culture medium amino <br /> proteases called plasmepsins cysteine proteases called                 acids (cysteine, glutamic acid, glutamine, isoleucine, methionine); Triple1, plasmepsins <br /> falcipains food vacuole (9&#226;&#8364;&#8220;12). All                 I&#229;&#8230;&#190;IV falcipain-2 triple knockout clone 1; Triple2, plasmepsins I&#229;&#8230;&#190;IV falcipain-2 triple <br /> capable degrading hemoglobin globin biochemical assays                  knockout clone 2; E64, trans-epoxysuccinyl-L-leucylamino(4-guanidine)-butane. <br />  <br /> using recombinant enzyme, order action                      *J.L. E.S.I. contributed equally work. <br /> unclear (9&#226;&#8364;&#8220;14). Inhibitors aspartic cysteine proteases kill               &#226;&#8364;&#160;To   correspondence addressed. E-mail: goldberg@borcim.wustl.edu. <br /> parasites culture animal models, specificity               &#194;&#169; 2006 The National Academy Sciences USA <br />  <br />  <br />  <br /> 8840 &#226;&#8364;&#8220; 8845 &#229;&#8230;&#169; PNAS &#229;&#8230;&#169; June 6, 2006 &#229;&#8230;&#169; vol. 103 &#229;&#8230;&#169; no. 23                                                                www.pnas.org&#229;&#8230;&#190;cgi&#229;&#8230;&#190;doi&#229;&#8230;&#190;10.1073&#229;&#8230;&#190;pnas.0601876103 <br />  Fig. 1. Amino acid requirements cultured WT parasites. (A) Flow cytometry starting culture cultures incubated different media 25 h. FITC-H <br /> channel histograms shown. The truncated, low fluorescence peaks correspond uninfected RBCs. RBCs infected mature parasites (schizonts) high <br /> fluorescence intensity correspond far-right peaks. RBCs infected younger (ring trophozoite) parasites closer uninfected RBC peak. <br /> A single amino acid omitted 5AA indicated. No AA used control (Lower Right). Parasitemia gates (defined Materials Methods) <br /> are shown horizontal bars, parasitemias listed underneath bar. Except starting culture Upper Left, media used listed bar. <br /> (B) Isoleucine dose dependence. Parasites incubated 51 h AA supplemented varying concentrations isoleucine. The y axis percent growth <br /> relative RPMI medium 1640. Error bars indicate SD triplicate measurements. (C) Effect 4-thiaisoleucine. Parasites cultured AA <br /> supplemented follows: lane a, addition; lane b, 15 &#226;?&#174;M isoleucine; lane c, 15 &#226;?&#174;M isoleucine plus 100 &#226;?&#174;M 4-thiaisoleucine. Gray bars indicate 51-h <br /> incubation; black bars indicate 124-h incubation. Representative experiments repeated times shown. <br />  <br />  <br />  <br /> contrast, omission isoleucine resulted stalled culture                     1640 containing 20 amino acids. Initial experiments were <br /> similar grown complete absence amino acids.                          using 382 &#226;?&#174;M isoleucine, concentration found <br />    We determined isoleucine itself sufficient                   RPMI medium 1640 (and 5AA). A titration isoleucine <br /> to support parasite growth. Remarkably, P. falciparum grown                        addition AA showed parasitemia 51 h saturated <br /> with isoleucine sole exogenous amino acid did better                   86% RPMI medium 1640, isoleucine <br /> in 5AA, growth nearly rich RPMI medium                      concentrations &#226;&#172;&#381;20 &#226;?&#174;M (Fig. 1B). No stimulation growth was <br />  <br />  <br />  <br />  <br />                                                                                                    Fig. 2. Creation chromosomal falcipain-2 disruption. (A) <br />                                                                                                    Schematic falcipain locus chromosome 11. PacI (P) <br />                                                                                                    digestion results fragments 4.0 kb (falcipain-2, FP2) and <br />                                                                                                    16.8 kb (falcipain-2&#226;&#172;&#732;, FP2&#226;&#172;&#732;). FP3, falcipain-3. (B) Schematic of <br />                                                                                                    falcipain-2 knockout plasmid. FP2&#226;&#8364;&#8220;5&#226;&#172;&#732; 590-bp fragment <br />                                                                                                    homologous 5&#226;&#172;&#732; coding region falcipain-2 gene. <br />                                                                                                    FP2&#226;&#8364;&#8220;3&#226;&#172;&#732; 605-bp fragment homologous 3&#226;&#172;&#732; coding <br />                                                                                                    region falcipain-2 gene. The 7.9-kb plasmid PacI <br />                                                                                                    site. BSD, blasticidin S-deaminase. (C ) Schematic falci- <br />                                                                                                    pain-2 knockout resulting double crossover. PacI diges- <br />                                                                                                    tion integrant concatenated plasmids yields a <br />                                                                                                    13.2-kb fragment. (D) Schematic falcipain-2 knockout <br />                                                                                                                                                                        MICROBIOLOGY <br />  <br />  <br />                                                                                                    resulting single crossover. This integration results a <br />                                                                                                    promoter-less copy falcipain-2, indicated FP2*. PacI <br />                                                                                                    digestion integrant concatenated plasmids <br />                                                                                                    results 26-kb fragment. (E) Southern blot PacI digested <br />                                                                                                    total DNA untransfected parasites (WT), falcipain-2 sin- <br />                                                                                                    gle knockout clones (FP2a, FP2b, FP2c, FP2d), plas- <br />                                                                                                    mepsins I IV, falcipain-2 triple knockout clones (Triple <br />                                                                                                    1 Triple 2). Wt-FP2 indicates fragment corresponding <br />                                                                                                    WT falcipain-2 locus, d-K&#229;&#8230;&#190;O indicates falcipain-2 <br />                                                                                                    knockout resulting double crossover, s-K&#229;&#8230;&#190;O indicates <br />                                                                                                    falcipain-2 knockout resulting single crossover. <br />                                                                                                    FP2&#226;&#8364;&#8220;5&#226;&#172;&#732; used Southern probe. Falcipain-2&#226;&#172;&#732;, al- <br />                                                                                                    identical copy falcipain-2 expressed later the <br />                                                                                                    life cycle (11), cross-hybridizes probe. DNA size lad- <br />                                                                                                    ders (in kb) shown right blots. <br />  <br />  <br /> Liu et al.                                                                                                  PNAS &#229;&#8230;&#169; June 6, 2006 &#229;&#8230;&#169; vol. 103 &#229;&#8230;&#169; no. 23 &#229;&#8230;&#169; 8841 <br />  seen going level higher RPMI <br /> medium 1640 (1,475 &#226;?&#174;M; data shown). We chose 147.5 &#226;?&#174;M <br /> as standard concentration AA supplemented with <br /> isoleucine sole amino acid (I medium). We able <br /> to culture P. falciparum clone 3D7 continuously &#226;&#172;&#381;2 months <br /> in medium. These data suggest P. falciparum use <br /> hemoglobin degradation main amino acid source. Because <br /> isoleucine absent human hemoglobin, parasite still <br /> auxotrophic amino acid. In support notion, <br /> parasite growth completely blocked 100 &#226;?&#174;M 4-thiaiso- <br /> leucine (Fig. 1C), blockade overcome high <br /> exogenous isoleucine concentrations (data shown). <br />  <br /> Growth Hemoglobin Degradation Enzyme <span id='am-240' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-241' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-242' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-243' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-244' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-245' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-246' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-247' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-248' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-249' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-250' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-251' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-252' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-253' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-254' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-255' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-256' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-257' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-258' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-259' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-260' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-261' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-262' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-263' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-264' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-265' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-266' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-267' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-268' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-269' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-270' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-271' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-272' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-273' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-274' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-275' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-276' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-277' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-278' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-279' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-280' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-281' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-282' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-283' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-284' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-285' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-286' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-287' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-288' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-289' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-290' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-291' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-292' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-293' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-294' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-295' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-296' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-297' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-298' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-299' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-300' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-301' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-302' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-303' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-304' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-305' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-306' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-307' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-308' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-309' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-310' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-311' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-312' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-313' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-314' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-315' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-316' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-317' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span>Gene Knockout</span> Lines in <br /> I Medium. Previous studies shown individual knock- <br /> outs of food vacuole plasmepsins falci- <br /> pain-2 nearly normal growth phenotypes RPMI me- <br /> dium 1640 (5, 16, 17). A plasmepsin IV&#229;&#8230;&#190;I double knockout has <br /> a doubling time &#226;&#172;&#8225;10% longer parental strain; this <br /> <span id='am-84' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-85' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-91' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-100' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-101' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-107' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-110' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-112' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-113' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-115' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-120' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-123' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-125' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-133' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-138' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-142' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-143' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-145' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-149' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-152' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-154' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-156' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-159' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-160' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-161' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span>phenotype</span> accentuated slightly 5AA (5). We constructed <br /> a triple knockout disrupting falcipain-2 plasmepsin <br /> IV&#229;&#8230;&#190;I double knockout background. For comparison, sim- <br /> ilarly disrupted falcipain-2 WT background. Southern <br /> blots (Fig. 2) revealed single-crossover recombination the <br /> correct locus both. Additionally, double-crossover recom- <br /> bination clones single falcipain-2 knockout. <br /> Two triple knockout clones [plasmepsins I&#229;&#8230;&#190;IV falcipain-2 <br /> triple knockout clone 1 (Triple1) plasmepsins I&#229;&#8230;&#190;IV and <br /> falcipain-2 triple knockout clone 2 (Triple2)] of <br /> the falcipain-2 single double crossover knockout clones <br /> (FP2b FP2c, respectively) chosen analysis. <br /> RT-PCR analysis (as ref. 17) confirmed falcipain-2 <br /> disruption (data shown). Each falcipain-2 knockout <br /> lines (including triple knockout) displayed transient <br /> swollen food vacuole phenotype, reported single              Fig. 3. Growth knockout clones RPMI medium 1640 (Lower) I <br /> falcipain-2 knockout (17). Knockout clones parental           medium (Upper). Parasitemias asynchronous cultures measured by <br /> lines grown RPMI medium 1640 I medium. In                   flow cytometry. Fold increases parasites calculated graphed <br /> RPMI medium 1640, falcipain-2 knockout clones                 time. Black diamonds indicate WT; blue diamonds indicate plasmepsin <br />                                                                         IV&#229;&#8230;&#190;I double knockout; red triangles indicate falcipain-2 single knockout clone <br /> slightly slower-growing WT parental line, the <br />                                                                         b; green inverse triangles indicate falcipain-2 single knockout clone c; purple <br /> double plasmepsin knockout triple knockouts                 triangles indicate Triple 1; yellow inverse triangles indicate Triple 2. Error bars <br /> 12&#226;&#8364;&#8220;14% slower doubling times WT parental line (Fig.            indicate SD triplicate measurements. Curves simulated expo- <br /> 3 Table 1). In contrast, growth knockout lines           nential growth model. The colors symbols used curves. <br /> substantially impaired I medium. Falcipain-2 knockouts           Doubling times calculated listed Table 1. <br /> 20% longer doubling times WT 4-fold <br /> fewer parasites end 7-day growth period. The <br /> plasmepsin double knockout grew 28% slower WT                      slightly sensitive, seen (5). Falcipain-2 <br /> (5-fold fewer parasites). The triple knockout grew 41%             knockout clones &#226;&#172;&#8225;30-fold sensitive, been <br /> slower doubling time WT (10-fold fewer parasites).                 reported (17). Triple knockout parasites comparable in <br /> Despite this, culture maintained slow exponential               sensitivity falcipain-2 single knockouts. All parasites were <br /> growth 3 weeks. The data suggest things. First,        substantially sensitive pepstatin A grown I <br /> parasites grow better degrade hemoglobin well,            medium. WT, falcipain-2, plasmepsin IV&#229;&#8230;&#190;I knockouts were <br /> even rich medium. Second, parasites grown                3- 5-fold sensitive I medium, suggesting parasites <br /> minimal medium, relying hemoglobin amino acid                  relying hemoglobin degradation primary amino acid <br /> source, falcipains plasmepsins important            source need plasmepsin activity optimal growth. When <br /> process overlapping functions.                                 important components plasmepsin falcipain families <br />                                                                         deleted (triple knockouts), growth I medium ex- <br /> Sensitivity Protease Inhibitors I Medium. To assess   quisitely sensitive pepstatin A, IC50 values nano- <br /> interrelationship families hemoglobin-degrading           molar range, hundreds fold values determined full <br /> proteases, treated knockout parasites cysteine              RPMI medium 1640. The heightened sensitivity compared with <br /> protease inhibitor trans-epoxysuccinyl- L -leucylamino(4-               falcipain-2 single knockout explained fact that <br /> guanidine)-butane (E64) (Fig. 4A) aspartic protease              plasmepsins IV I food vacuole plasmepsins that <br /> inhibitor pepstatin A (Fig. 4B). Growth parasite lines       order magnitude sensitive pepstatin A the <br /> slightly sensitive E64 I medium RPMI medium          (9). When knocked out, remaining plas- <br /> 1640 (Fig. 4A, linear concentration scale, Table 2). More           mepsins easily inhibited. The data suggest blocking <br /> dramatic differences seen parasites grown pepstatin        plasmepsins falcipain-2 food vacuole forces a <br /> A (Fig. 4B, logarithmic concentration scale, Table 2). In           reliance exogenous amino acids survival. Growth slowed <br /> RPMI medium 1640, WT parasites poorly sensitive                 parasites impaired hemoglobin degradation in <br /> pepstatin A plasmepsin double knockout parasites               RPMI medium 1640 (see Fig. 4) halted I medium. The <br />  <br /> 8842 &#229;&#8230;&#169; www.pnas.org&#229;&#8230;&#190;cgi&#229;&#8230;&#190;doi&#229;&#8230;&#190;10.1073&#229;&#8230;&#190;pnas.0601876103                                                                                               Liu et al. <br />  Table 1. Doubling times (T) calculated simulation                            Table 2. Estimated IC50 values inhibition curves Fig. 4 <br /> curves Fig. 3                                                                                      Pepstatin A, IC50, &#226;?&#174;M                 E64, IC50, &#226;?&#174;M <br />                            I medium                       RPMI medium 1640 <br /> Parasite                                                                              Parasite        RPMI                I             RPMI               I <br /> clone               T, h           % WT               T, h           % WT       clone        medium 1640         medium        medium 1640        medium <br />  <br /> WT                  16.4              100               14.6               100        WT                 60              31                4.4              2.8 <br /> PM4&#229;&#8230;&#190;1               21.0              128               16.3               112        PM 4&#229;&#8230;&#190;1             70              22                3.6              2.1 <br /> FP2b                20.2              123               15.6               107        FP2b               2.3              0.5              1.8              1.3 <br /> FP2c                19.3              118               15.6               108        FP2c               3.3              0.6              2.0              1.2 <br /> Triple 1            23.2              141               16.5               113        Triple 1           2.1             &#226;&#172;?0.2              2.1              0.8 <br /> Triple 2            23.2              141               16.7               114        Triple 2           2.1             &#226;&#172;?0.1              1.9              0.8 <br />  <br />    PM4&#229;&#8230;&#190;1, plasmepsin I&#229;&#8230;&#190;IV double knockout; FP2b, falcipain-2 single knockout             PM4&#229;&#8230;&#190;1, plasmepsin I&#229;&#8230;&#190;IV double knockout; FP2b, falcipain-2 single knockout <br /> clone b; FP2c, falcipain-2 single knockout clone c.                                   clone b; FP2c, falcipain-2 single knockout clone c. <br />  <br />  <br />  <br /> flip falcipain axis fully operational (WT                    biochem). The IC50 value RPMI medium 1640-cultured 3D7 <br /> or plasmepsin double knockout) blockade plasmepsins                        parasites old pepstatin A (7 &#226;?&#174;M) line published <br /> only small effect parasites, organism relying                   reports (5, 15, 17), IC50 new preparations was <br /> on hemoglobin degradation amino acid supply (I medium).                           higher (&#226;&#172;&#8225;60 &#226;?&#174;M; Table 2). Inhibition curves various <br />                                                                                       knockout clones quite similar old pepstatin A (Fig. 5, <br /> Pepstatin A. We noted discrepancy potency                            published supporting information PNAS web <br /> 5-year-old pepstatin A (<span id='am-3' about='protege:FROM' typeof='owl:Thing'>from</span> Streptomyces sp., Sigma) fresh                       site) new, synthetic pepstatin A (Fig. 4B) shifted order <br /> pepstatin A (from Streptomyces sp., Sigma) synthetic (Cal-                         magnitude. We chose present data using new <br />                                                                                       pepstatin A better-defined reagent (chemically <br />                                                                                       synthesized peptide compared partially purified microbial <br />                                                                                       extract). Analysis preparations liquid chromatogra- <br />                                                                                       phy&#229;&#8230;&#190;MS (Fig. 6, published supporting information on <br />                                                                                       PNAS web site) revealed dominant component, <br />                                                                                       identified pepstatin A MS. There number of <br />                                                                                       contaminants old pepstatin A preparation. A newer Sigma <br />                                                                                       pepstatin A contained fewer contaminants (data shown) and <br />                                                                                       potency similar synthetic version. Titration pep- <br />                                                                                       statin A protease inhibitory activity plasmepsin II enzyme <br />                                                                                       (Fig. 7, published supporting information the <br />                                                                                       PNAS web site) revealed superimposable quantities aspartic <br />                                                                                       protease-inhibitory activity old synthetic pepstatin A <br />                                                                                       preparations. We conclude likely contam- <br />                                                                                       inant old pepstatin A increased potency. <br />  <br />                                                                                       Discussion <br />                                                                                       We P. falciparum grow culture with <br />                                                                                       isoleucine sole exogenous amino acid. Previous studies, <br />                                                                                       rich RPMI medium 1640, suggested parasite <br />                                                                                       excretes amino acids hemoglobin degradation <br />                                                                                       hemoglobin degradation minimal im- <br />                                                                                       portance amino acid source organism (6). In <br />                                                                                       contrast, force parasites rely hemoglobin degra- <br />                                                                                       dation, (except need isoleucine sup- <br />                                                                                       plementation absent human hemoglobin). The <br />                                                                                       finding physiologically relevant the <br />                                                                                       children malaria endemic regions malnourished and <br />                                                                                       contain low, undetectable, levels plasma amino acids (19, <br />                                                                                       20). Indeed, RPMI medium 1640 higher concentration for <br />                                                                                                                                                                      MICROBIOLOGY <br />  <br />  <br />  <br />                                                                                       amino acids (up 20 times) normal plasma (21, 22). <br />                                                                                          Our studies P. falciparum strain 3D7, because <br />                                                                                       parental background knockouts. We have <br /> Fig. 4. Sensitivities protease inhibitors. (A) E64 sensitivities. Parasites   tested number isolates addition to <br /> incubated E64 62 h. The percent growth cultures compared             isoleucine strains need methionine supplementation for <br /> the untreated culture graphed E64 concentration linear scale.           optimal growth (unpublished results). Methionine present at <br /> Solid diamonds solid lines indicate I medium; open diamonds dotted            low (1%) levels human hemoglobin, endogenous <br /> lines indicate RPMI medium 1640. Error bars indicate SD triplicate             supply borderline adequate. Seven-day growth 3D7 is <br /> measurements. PM4&#229;&#8230;&#190;1, plasmepsin I&#229;&#8230;&#190;IV double knockout; FP2b, falcipain-2 <br />                                                                                       better I medium 5AA (5), isoleucine <br /> single knockout clone b; FP2c, falcipain-2 single knockout clone c. (B) Pepstatin <br /> A sensitivities. Parasites incubated pepstatin A 63 h. The percent <br />                                                                                       concentration identical. We understand reason for <br /> growth cultures compared untreated culture graphed             difference, appears unlikely simple <br /> pepstatin A concentration log10 scale. Symbols lines        competition uptake isoleucine, increasing the <br /> A. E64 pepstatin A IC50 values listed Table 2.                             isoleucine 5AA does improve growth (data shown). <br />  <br /> Liu et al.                                                                                                     PNAS &#229;&#8230;&#169; June 6, 2006 &#229;&#8230;&#169; vol. 103 &#229;&#8230;&#169; no. 23 &#229;&#8230;&#169; 8843 <br />  Perhaps complex cotransport countertrans-             CO2, 5% O2, 90% N2. Full RPMI medium 1640 standard <br /> port phenomenon interesting study.                      RPMI medium 1640 (Invitrogen) containing 20 amino acids and <br />    Our knockout inhibitor studies clearly parasites        supplemented 27 mM NaHCO3, 22 mM glucose, 0.37 mM <br /> with impaired hemoglobin degradation machinery grow better            hypoxanthine, 10 &#226;?&#174;g&#229;&#8230;&#190;ml gentamicin, 5 g&#229;&#8230;&#190;liter Albumax (In- <br /> full RPMI medium 1640 I medium. Therefore, provision             vitrogen). RPMI medium 1640 lacking amino acids (no AA) was <br /> of exogenous amino acids overcome slowed hemoglobin                  custom-made tissue culture center Washington <br /> degradation. If hemoglobin degradation drastically attenu-            University School Medicine. Single amino acids (isoleucine, <br /> ated, however, falcipain-2 knockout parasites treated         glutamine, glutamate, methionine, cysteine; Sigma) were <br /> pepstatin A, RPMI medium 1640                 added concentrations RPMI medium 1640 make <br /> promote growth. Some hemoglobin degradation neces-                5AA. Isoleucine added 147.5 &#226;?&#174;M make I medium. <br /> sary survival independent amino acid generation. For              Supplements added RPMI medium 1640 above. I <br /> example, protease classes overlapping func-           medium supplemented dialyzed Albumax gave similar results <br /> tion process egress osmotic regulation.            undialyzed Albumax. <br /> Alternatively, <span id='am-2' about='Thesaurus:Nutrient' typeof='owl:Thing'>nutrient</span> parasite derives <br /> from hemoglobin accessed medium.                 Disruption Falcipain-2 Gene. Two fragments falcipain-2 <br /> Plasmodium iron acquisition poorly understood,           gene amplified genomic DNA using primers <br /> much heme hemoglobin sequestered                   GGTTAAGCTTATGGATTACAACATGG GGTTA- <br /> parasite hemozoin, possible parasite relies         AGCTTGTTATGCATATTTACTTTG 5&#226;&#172;&#732; fragment (590 <br /> release small iron metabolism (23). An            bp, called FP2&#226;&#8364;&#8220;5&#226;&#172;&#732;) CCTGAATTCGGATCTTGCTGGGC- <br /> amino acid conceivably inaccessible               CTTTAG GGTGAATTCTTAGGCAATTAATGGATG <br /> external medium.                                                         3&#226;&#172;&#732; fragment (605 bp, called FP2&#226;&#8364;&#8220;3&#226;&#172;&#732;). FP2&#226;&#8364;&#8220;5&#226;&#172;&#732; FP2&#226;&#8364;&#8220;3&#226;&#172;&#732; <br />    Amino acid acquisition clearly important process        sequenced cloned knockout vector, a <br /> malaria parasite, reflected multiple layers redun-        modified version pHC1 (26). In modified vector, select- <br /> dancy. The ability use exogenous (RPMI medium 1640)                able marker BSD (27) driven PcDT promoter element. For <br /> endogenous (hemoglobin) amino acids primary source           single gene falcipain-2 knockout, parental 3D7 culture (WT) <br /> layer, described above. The presence multiple plasmepsins          transfected plasmid described (5) grown the <br /> with overlapping specificity function (5, 9) multiple            presence 3.5 &#226;?&#174;g&#229;&#8230;&#190;ml blasticidin 2 weeks. The culture then <br /> falcipains overlap (24) layer. The final      subjected drug cycle (21-day growth drug, followed <br /> layer, gained insight, redundancy         reselection blasticidin parasites reappeared). For the <br /> between falcipain plasmepsin families. Knockout               triple knockout plasmepsins I IV, falcipain-2, plasmep- <br /> falcipain-2 minimal effect parasite growth rich <br />                                                                          sin knockout clone PMIV&#229;&#8230;&#190;I A5 (5) transfected the <br /> medium (ref. 17 work) significant, not <br />                                                                          falcipain-2 knockout vector cycled twice. Parasites cloned <br /> lethal, effect I medium (4-fold growth defect 1 week). <br />                                                                          method limiting dilution. Vector integration analyzed <br /> Knockout individual plasmepsins gives similar results (5). <br />                                                                          Southern blot described (5). <br /> Knockout components families combination was <br /> nearly additive, suggesting overlap function families. <br />                                                                          Flow Cytometry. P. falciparum cultures stained 0.5 <br /> The results suggest gene duplication enzymes may <br />                                                                          &#226;?&#174;g&#229;&#8230;&#190;ml acridine orange (Molecular Probes) PBS used <br /> have selected provide increased protease dosage rather <br /> than sophisticated complementary cleavage               1 h. A total 3 &#226;&#171;&#187; 104 cells sample counted on <br /> specificities. It noted current study,        BD Biosciences Canto flow cytometer. The FITC channel <br /> selected gene knockouts produced. It possible         detector records green fluorescence acridine orange when <br /> plasmepsin falcipain knockouts combination           binds DNA (maximum emission 525 nm), the <br /> be crucial parasite growth. More study required.                  phycoerythrin (PE) channel detector records red fluores- <br />    Pepstatin A treatment minimal effect WT parasites            cence acridine orange binds RNA (maximum <br /> except high concentrations killed falcipain-2 knockout       emission 650 nm). Both channels distinguish parasite- <br /> clones potently. The effects dramatic I medium,        infected RBC uninfected RBC based DNA or <br /> and triple knockout, low nanomolar concentrations killed          RNA content differences. Forward size scattering (FSC) was <br /> parasites. The fact pepstatin A kills parasites impaired         used count total cell number. For channels, <br /> hemoglobin degradation, especially forced rely       peak height signals (FITC-H, PE-H, FSC-H) used for <br /> hemoglobin amino acid source, strongly suggests pep-          analysis F LOWJO software (Treestar, Ashland, OR). Para- <br /> statin A able food vacuole block aspartic         sitemia gates defined population cells having <br /> protease function. It long suspected pepstatin A got       intense signals FITC-H PE-H channels distinct <br /> into cells poorly, accounting low potency cultured       main body cells (uninfected RBCs). Gating of <br /> parasites. Rather, data suggest pepstatin A effective    parasite populations verified blood smears. For the <br /> on WT parasites blockade plasmepsins lethal.           experiment Fig. 4, culture fixed 0.05% glutaraldehyde <br /> Dozens laboratories hundreds compounds targeted          PBS stored 4&#194;&#176;C. The cells permeabilized with <br /> to plasmepsins (25). None potent pepstatin A        0.25% Triton X-100 PBS 5 min room temperature and <br /> isolated enzyme, limited efficacy cultured parasites.    stained 0.5 &#226;?&#174;g&#229;&#8230;&#190;ml acridine orange use. Parasite <br /> Again, bioavailability thought limitation,      growth rate calculated reported (5). <br /> current data suggest bioefficacy problem. Food <br /> vacuole plasmepsin inhibition does appear promising          Inhibition Assay. Asynchronous cultures starting parasitemia <br /> strategy antimalarial drug development, unless combined         1&#226;&#8364;&#8220;1.5% incubated varying amounts E64 <br /> falcipain inhibition.                                                    (Sigma) synthetic pepstatin A (Calbiochem) without <br />                                                                          inhibitor (control culture) 62 63 h medium <br /> Materials Methods                                                    indicated. Parasitemias counted f low cytometry, and <br /> Parasite Culture. P. falciparum strain 3D7 derived knockout          increase parasitemia (relative control culture set to <br /> lines cultured described (5). Briefly, asexual-stage parasites   100%) graphed inhibitor concentration. In another <br /> were grown human O&#226;&#171;&#185; erythrocytes 2% hematocrit 5%            series experiments, culture incubated without <br />  <br /> 8844 &#229;&#8230;&#169; www.pnas.org&#229;&#8230;&#190;cgi&#229;&#8230;&#190;doi&#229;&#8230;&#190;10.1073&#229;&#8230;&#190;pnas.0601876103                                                                                  Liu et al. <br />  4-thiaisoleucine (Sigma) times indicated analyzed                              This study supported National Institutes Health Grant <br /> as above.                                                                                  AI47798. <br />  <br />  <br />  1. Loria, P., Miller, S., Foley, M. &amp; Tilley, L. (1999) Biochem. J. 339, 363&#226;&#8364;&#8220;370.         15. Bailly, E., Jambou, R., Savel, J. &amp; Jaureguiberry, G. (1992) J. Protozool. 39, <br />  2. Goldberg, D. E. (2005) Malaria: Drugs, Disease, Post-Genomic Biology,               593&#226;&#8364;&#8220;599. <br />     eds. Sullivan, D. &amp; Krishna, S. (Springer, Berlin), pp. 275&#226;&#8364;&#8220;291.                       16. Omara-Opyene, A. L., Moura, P. A., Sulsona, C. R., Bonilla, J. A., Yowell, <br />  3. Sherman, I. W. (1977) Bull. W. H. O. 55, 265&#226;&#8364;&#8220;276.                                          C. A., Fujioka, H., Fidock, D. A. &amp; Dame, J. B. (2004) J. Biol. Chem. 279, <br />  4. Divo, A. A., Geary, T. G., Davis, N. L. &amp; Jensen, J. B. (1985) J. Protozool. 32,           54088&#226;&#8364;&#8220;54096. <br />     59&#226;&#8364;&#8220;64.                                                                                 17. Sijwali, P. S. &amp; Rosenthal, P. J. (2004) Proc. Natl. Acad. Sci. USA 101, <br />  5. Liu, J., Gluzman, I. Y., Drew, M. E. &amp; Goldberg, D. E. (2005) J. Biol. Chem.               4384&#226;&#8364;&#8220;4389. <br />     280, 1432&#226;&#8364;&#8220;1437.                                                                        18. Payne, S. H. &amp; Loomis, W. F. (2006) Eukaryot. Cell 5, 272&#226;&#8364;&#8220;276. <br />  6. Krugliak, M., Zhang, J. &amp; Ginsburg, H. (2002) Mol. Biochem. Parasitol. 119,            19. Whitehead, R. G. &amp; Dean, R. F. (1964) Am. J. Clin. Nutr. 14, 313&#226;&#8364;&#8220;319. <br />     249&#226;&#8364;&#8220;256.                                                                               20. Baertl, J. M., Placko, R. P. &amp; Graham, G. G. (1974) Am. J. Clin. Nutr. 27, <br />  7. Lew, V. L., Tiffert, T. &amp; Ginsburg, H. (2003) Blood 101, 4189&#226;&#8364;&#8220;4194.                        733&#226;&#8364;&#8220;742. <br />  8. Allen, R. J. &amp; Kirk, K. (2004) Trends Parasitol. 20, 7&#226;&#8364;&#8220;10. <br />                                                                                            21. Aguilo, A., Castano, E., Tauler, P., Guix, M. P., Serra, N. &amp; Pons, A. (2000) <br />  9. Banerjee, R., Liu, J., Beatty, W., Pelosof, L., Klemba, M. &amp; Goldberg, D. E. <br />                                                                                                J. Nutr. Biochem. 11, 81&#226;&#8364;&#8220;86. <br />     (2002) Proc. Natl. Acad. Sci. USA 99, 990&#226;&#8364;&#8220;995. <br />                                                                                            22. Jones, D. P., Carlson, J. L., Mody, V. C., Cai, J., Lynn, M. J. &amp; Sternberg, P. <br /> 10. Shenai, B. R., Sijwali, P. S., Singh, A. &amp; Rosenthal, P. J. (2000) J. Biol. Chem. <br />                                                                                                (2000) Free Radical Biol. Med. 28, 625&#226;&#8364;&#8220;635. <br />     275, 29000&#226;&#8364;&#8220;29010. <br /> 11. Singh, N., Sijwali, P. S., Pandey, K. C. &amp; Rosenthal, P. J. (2006) Exp. Parasitol.     23. Loyevsky, M. &amp; Gordeuk, V. R. (2001) Antimalarial Chemotherapy, Mech- <br />     112, 187&#226;&#8364;&#8220;192.                                                                              anism Action, Resistance, New Directions Drug Discovery, ed. <br /> 12. Sijwali, P. S., Shenai, B. R., Gut, J., Singh, A. &amp; Rosenthal, P. J. (2001) Biochem.       Rosenthal, P. J. (Humana, Totowa, NJ), pp. 307&#226;&#8364;&#8220;324. <br />     J. 360, 481&#226;&#8364;&#8220;489.                                                                       24. Dahl, E. L. &amp; Rosenthal, P. J. (2005) Mol. Biochem. Parasitol. 139, 205&#226;&#8364;&#8220;212. <br /> 13. Banerjee, R. &amp; Goldberg, D. E. (2001) Antimalarial Chemotherapy, Mech-              25. Boss, C., Richard-Bildstein, S., Weller, T., Fischli, W., Meyer, S. &amp; Binkert, C. <br />     anism Action, Resistance, New Directions Drug Discovery, ed.                     (2003) Curr. Med. Chem. 10, 883&#226;&#8364;&#8220;907. <br />     Rosenthal, P. J. (Humana, Totowa, NJ), pp. 43&#226;&#8364;&#8220;63.                                      26. Crabb, B. S., Triglia, T., Waterkeyn, J. G. &amp; Cowman, A. F. (1997) Mol. <br /> 14. Rosenthal, P. J. (2001) Antimalarial Chemotherapy, Mechanisms Action,                Biochem. Parasitol. 90, 131&#226;&#8364;&#8220;144. <br />     Resistance, New Directions Drug Discovery, ed. Rosenthal, P. J. (Humana,        27. Mamoun, C. B., Gluzman, I. Y., Goyard, S., Beverley, S. M. &amp; Goldberg, D. E. <br />     Totowa, NJ), pp. 325&#226;&#8364;&#8220;345.                                                                  (1999) Proc. Natl. Acad. Sci. USA 96, 8716&#226;&#8364;&#8220;8720. <br />  <br />  <br />  <br />  <br />                                                                                                                           <br /> </body></html>